After the company he co-founded was forced to close due to a copyright lawsuit last December, Andrew Arruda, co-founder and former CEO of legal research startup ROSS Intelligence, has now taken the helm as CEO of a new software company, this time in the medical field.
Arruda announced the company Automate Medical in a post on Medium yesterday. The company plans to develop products to digitize data from diagnostic tests and laboratory reports, and then create analytical dashboards for health professionals to interpret and analyze that data.
Thomas Hamilton, Vice President Strategy and Operations at ROSS, joins Arruda as Co-Founder and COO. A third co-founder and CTO is Joshua Kelly, who was previously the CTO of Universe.com.
Arruda said that Automate Medical raised a pre-seed round of $ 2 million, led by Apollo Projects, a mutual fund founded last year by Sam Altman, CEO of OpenAI and past president of Y Combinator, to support Moonshot starts.
“At Automate Medical, we envision a world where software and data science will play an essential role in diagnosing and treating all diseases in the future,” wrote Arruda. ”
Our software ensures that patients not only receive the best possible treatment, but also personalized drug and treatment plans that are compared based on data rather than depending on the individual experience of a particular doctor or group. “
Arruda, a former lawyer, and two computer scientists, Jimoh Ovbiagele and Pargles Dall’Oglio, founded ROSS in 2014 at the University of Toronto as a student participant in an IBM-hosted cognitive computing competition to develop applications for the Watson computer. After winning that competition and gaining media coverage as an AI platform that could one day replace lawyers, ROSS quickly gained momentum.
Soon the founders were invited to Silicon Valley to take part in the renowned Y-Combinator startup incubator. Denton’s NextLaw Labs made ROSS one of its earliest investments. In 2015, they secured start-up funding of $ 4.3 million and two years later another Series A funding of $ 8.7 million. In 2017 Forbes named the three founders their “30 Under 30”.
I wrote a long chunk about ROSS after visiting the Toronto Research and Development office in 2019, where I also recorded a LawNext episode with Arruda and Ovbiagele.
Last May, Thomson Reuters filed a lawsuit against ROSS alleging that Westlaw stole content in order to develop its own competing legal research product. Although ROSS denied these allegations and vowed to fight the lawsuit, which it continues to do, the cost of fighting the case forced Ross to announce last December that it would cease operations.
“This is not our first rodeo,” wrote Arruda yesterday of the co-founders of his new company. “We are a team from law and finance with an eye for detail, deep comfort with large amounts of data and the background to develop intuitive technology for busy professionals.”